Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Atorvastatin is one of a group of statins widely used to treat heart and blood vessel diseases. The medication works by lowering cholesterol in the blood. This new study shows that atorvastatin influences the way people experience certain emotions, giving us important insights about disorders such as anxiety and depression.

The collage of faces of surprised people on coloured backgrounds.

This experimental medicine trial investigated the effects of atorvastatin on emotional processing, reward learning, verbal memory and inflammation in healthy volunteers.

Participants took atorvastatin for seven days and they were subsequently more likely to identify faces showing fearful emotions. 

The study results reveal for the first time the early influence of atorvastatin on emotional recognition of fear - something that is linked to anxiety and depression, as well as the effects of commonly-used antidepressants on these conditions.

Dr Riccardo De Giorgi, study author and Wellcome Trust Doctoral Training Fellow, University of Oxford, said:

 

'Our findings are important because they show for the first time that a very commonly prescribed medication, atorvastatin, can affect the way we perceive certain emotions. This is relevant to further studies investigating whether statins could be used for treating depressive and anxiety disorders.'

Read the full study, The effects of atorvastatin on emotional processing, reward learning, verbal memory and inflammation in healthy volunteers: An experimental medicine study, in the Journal of Psychopharmacology 

NIHR OXFORD HEALTH BIOMEDICAL RESEARCH CENTRE NEWS

Please follow the link below to read the news on the NIHR BRC website.

Similar stories

New study reveals clinical instability can predict psychiatric hospitalisation

For patients with psychiatric conditions, data shows that both illness severity and instability are key factors in predicting their future risk of hospitalisation.

Kam Bhui joins MQ Science Council

Professor Kam Bhui appointed to MQ’s Science Council, a group of global experts who guide MQ’s research.

Ensuring LGBTQI+ people are treated fairly in mental health data

Andrey Kormilitzin outlines a new participatory study aimed at improving AI to take account of LGBTQI+ people so that their needs are better met by mental health services.

Friendship and mental health in adolescents

Tanya Manchanda's new paper investigates the role of friendship on the mental health outcomes of adolescents

Major wellbeing survey for 9-18 year olds launched

Researchers at Oxford are encouraging schools and colleges in four areas of the country to sign up to be part of the OxWell Student Survey.

‘Thinking Family’ when an adult has a serious illness

New research shows that although patient’s family details were often recorded, this information was not routinely used to help patients share their diagnosis with children.